| Nov 21 |
QSI
|
Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event |
| Nov 20 |
ILMN
|
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2 |
| Nov 20 |
ILMN
|
If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer |
| Nov 20 |
ILMN
|
Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Wolfe Research 2024 Healthcare Conference (Transcript) |
| Nov 20 |
QSI
|
Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results |
| Nov 20 |
QGEN
|
Morgan Stanley lists hedge funds’ largest Q3 ownership increases in Russell 1000 stocks |
| Nov 20 |
ILMN
|
Illumina gear up to expand TruSight Oncology portfolio |
| Nov 20 |
QSI
|
Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology |
| Nov 20 |
ILMN
|
ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio |
| Nov 20 |
QSI
|
Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA |
| Nov 20 |
QSI
|
Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform |
| Nov 20 |
QSI
|
Quantum-Si and Planet Innovation to Partner on Proteus™ |
| Nov 20 |
PACB
|
Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now |
| Nov 19 |
ILMN
|
Illumina announces expansion of TruSight Oncology portfolio |
| Nov 19 |
HYPR
|
Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings |
| Nov 18 |
QSI
|
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| Nov 18 |
ILMN
|
Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now? |
| Nov 16 |
HYPR
|
Hyperfine Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line |
| Nov 15 |
ILMN
|
Life sciences stocks viewed positively at TD Cowen despite post-election weakness |
| Nov 15 |
HYPR
|
Is Hyperfine (NASDAQ:HYPR) In A Good Position To Invest In Growth? |
